Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment

by Christian Martin Seitz, Christian Martin Seitz, Tim Flaadt, Markus Mezger, Anne-Marie Lang, Anne-Marie Lang, Sebastian Michaelis, Marie Katz, Desireé Syring, Alexander Joechner, Alexander Joechner, Armin Rabsteyn, Armin Rabsteyn, Nikolai Siebert, Sascha Troschke-Meurer, Maxi Zumpe, Holger N. Lode, Sile F. Yang, Daniel Atar, Anna-Sophia Mast, Sophia Scheuermann, Florian Heubach, Rupert Handgretinger, Rupert Handgretinger, Peter Lang, Peter Lang, Patrick Schlegel, Patrick Schlegel, Patrick Schlegel, Patrick Schlegel, Patrick Schlegel
Published 2021-07-01